Quality of Life in Childhood Immune Thrombocytopenia: International Validation of the Kids' ITP Tools

被引:36
作者
Klaassen, Robert J. [1 ]
Blanchette, Victor [2 ]
Burke, Tricia A. [3 ]
Wakefield, Cindy [2 ]
Grainger, John D. [4 ]
Gaedicke, Gerhard [5 ]
Riedlinger, Arne [5 ]
Dufort, Gustavo [6 ]
Citrin, Estela [7 ]
Reguerre, Yves [8 ]
Pellier, Isabelle [8 ,9 ]
Curtis, Christine [2 ]
Young, Nancy L. [3 ]
机构
[1] Childrens Hosp Eastern Ontario, Dept Pediat, Div Hematol Oncol, Ottawa, ON K1H 8L1, Canada
[2] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada
[3] Laurentian Univ, Sudbury, ON P3E 2C6, Canada
[4] Royal Manchester Childrens Hosp, Manchester M27 1HA, Lancs, England
[5] Charite Univ Med Berlin, Campus Virchow Klinikum, Berlin, Germany
[6] Hosp Pereira Rossell, Montevideo, Uruguay
[7] Lab Clausen, Montevideo, Uruguay
[8] Ctr Hosp Univ Angers, Angers, France
[9] Ctr Rech Cancerol, Nantes, France
基金
加拿大健康研究院;
关键词
child; comparative study; idiopathic; multicenter study; parents; purpura; quality of life; questionnaires; reproducibility of results; thrombocytopenic; RANDOMIZED-TRIAL; ORAL PREDNISONE; PURPURA; CHILDREN; RELIABILITY; VALIDITY; PEDSQL(TM)-4.0; ROMIPLOSTIM; HEMORRHAGE; AGREEMENT;
D O I
10.1002/pbc.24257
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. The Kids ITP Tools (KIT) is a disease-specific measure of health-related quality of life for children with immune thrombocytopenia (ITP). To facilitate use in international trials it has been cross-culturally adapted for France, Germany, the United Kingdom and Uruguay. This study assessed the validity and reliability of the translated KIT in comparison to generic quality of life measures. Methods. Children 2-18 years of age with ITP and their parents were recruited in France, Germany, the United Kingdom and Uruguay. Participants completed the KIT, PedsQL and KINDL. We examined the Pearson's correlation between these measures for our pooled sample and estimated the reliability over a 2-week time period. Findings were further explored by country. Results. A total of 127 families (81 children self-reported) participated. Mean child-reported scores were: KIT 74.3 (SD = 15.3), PedsQL 81.3 (SD = 13.0), and KINDL 70.5 (SD = 14.3). Corresponding mean parent proxy-reported scores were: 70.6 (SD = 18.1), 75.7 (SD = 16.8) and 72.3 (SD = 12.7), respectively. Correlation between KIT and the generic measures was consistent with our a priori hypothesis (PedsQL r = 0.54, KINDL r = 0.48, both P < 0.0001). Child KIT scores for newly diagnosed ITP patients were significantly lower than for chronic ITP patients (67.3 vs. 77.3; P = 0.005). There was a significant correlation (P < 0.001) between the child and parent proxy KIT scores (ICC = 0.52). Child KIT test-retest reliability was acceptable at 0.71. Conclusions. The cross-culturally translated KIT is valid and reliable with acceptable correlation to the PedsQL and KINDL. There is a significant difference in child self-reported KIT scores between newly diagnosed and chronic ITP. Pediatr Blood Cancer 2013; 60: 95-100. (C) 2012 Wiley Periodicals, Inc.
引用
收藏
页码:95 / 100
页数:6
相关论文
共 25 条
[1]   RANDOMIZED TRIAL OF INTRAVENOUS IMMUNOGLOBULIN-G, INTRAVENOUS ANTI-D, AND ORAL PREDNISONE IN CHILDHOOD ACUTE IMMUNE THROMBOCYTOPENIC PURPURA [J].
BLANCHETTE, V ;
IMBACH, P ;
ANDREW, M ;
ADAMS, M ;
MCMILLAN, J ;
WANG, E ;
MILNER, R ;
ALI, K ;
BARNARD, D ;
BERNSTEIN, M ;
CHAN, KW ;
ESSELTINE, D ;
DEVEBER, B ;
ISRAELS, S ;
KOBRINSKY, N ;
LUKE, B .
LANCET, 1994, 344 (8924) :703-707
[2]   A PROSPECTIVE, RANDOMIZED TRIAL OF HIGH-DOSE INTRAVENOUS IMMUNE GLOBULIN G THERAPY, ORAL PREDNISONE THERAPY, AND NO THERAPY IN CHILDHOOD ACUTE IMMUNE THROMBOCYTOPENIC PURPURA [J].
BLANCHETTE, VS ;
LUKE, B ;
ANDREW, M ;
SOMMERVILLENIELSEN, S ;
BARNARD, D ;
DEVEBER, B ;
GENT, M .
JOURNAL OF PEDIATRICS, 1993, 123 (06) :989-995
[3]   Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines [J].
BoltonMaggs, PHB ;
Moon, I .
LANCET, 1997, 350 (9078) :620-623
[4]   Psychometric properties of the KINDL-R questionnaire: results of the BELLA study [J].
Bullinger, Monika ;
Bruett, Anna Levke ;
Erhart, Michael ;
Ravens-Sieberer, Ulrike .
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2008, 17 (Suppl 1) :125-132
[5]   SAMPLE-SIZE REQUIREMENTS FOR RELIABILITY STUDIES [J].
DONNER, A ;
ELIASZIW, M .
STATISTICS IN MEDICINE, 1987, 6 (04) :441-448
[6]  
Engelen V, 2011, PEDIAT BLOOD CANC
[7]   Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials [J].
George, James N. ;
Mathias, Susan D. ;
Go, Ronald S. ;
Guo, Matthew ;
Henry, David H. ;
Lyons, Roger ;
Redner, Robert L. ;
Rice, Lawrence ;
Schipperus, Martin R. .
BRITISH JOURNAL OF HAEMATOLOGY, 2009, 144 (03) :409-415
[8]   Monitoring health-related quality of life in paediatric practice: development of an innovative web-based application [J].
Haverman, Lotte ;
Engelen, Vivian ;
van Rossum, Marion A. J. ;
Heymans, Hugo S. A. ;
Grootenhuis, Martha A. .
BMC PEDIATRICS, 2011, 11
[9]   Intracranial hemorrhage in children with immune thrombocytopenic purpura [J].
Iyori, H ;
Bessho, F ;
Ookawa, H ;
Konishi, S ;
Shirahata, A ;
Miyazaki, S ;
Fujisawa, K ;
Akatsuka, J .
ANNALS OF HEMATOLOGY, 2000, 79 (12) :691-695
[10]   Validity, reliability, and responsiveness of a new measure of health-related quality of life in children with immune thrombocytopenic purpura: The kids' ITP tools [J].
Klaassen, Robert J. ;
Blanchette, Victor S. ;
Barnard, Dorothy ;
Wakefield, Cindy D. ;
Curtis, Christine ;
Bradley, Catharine S. ;
Neufeld, Ellis J. ;
Buchanan, George R. ;
Silva, Mariana P. ;
Chan, Anthony K. C. ;
Young, Nancy L. .
JOURNAL OF PEDIATRICS, 2007, 150 (05) :510-515